Daily Bulletin

Men's Weekly

.

New data independently confirms and extends laboratory findings and expands safety profile of ATH434-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

MELBOURNE, Australia and SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced that new clinical and experimental pharmacology data for its lead drug candidate ATH434 (formerly PBT434) has been selected for presentation at the 2020 International Congress of...

Read more: New data independently confirms and extends laboratory findings and expands safety profile of...

More Articles ...

  1. Tile™ and Skullcandy Create Most Advanced True Wireless Finding Experience-PR Newswire APAC
  2. Trade360 Announces New Trading Platform-PR Newswire APAC
  3. Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report-PR Newswire APAC

Business News

How HZad Education Supports International Students Preparing for CELPIP in Australia

As Australia officially accepts CELPIP (Canadian English Language Proficiency Index Program) for visa applications, international students face new opportunities alongside unprecedented preparation ch...

Daily Bulletin - avatar Daily Bulletin

Online Site Inductions for Busy HR Teams

Induct For Work, the Australian platform for frontline onboarding and compliance, has launched Compliance Hub, a fully integrated, real-time workflow designed specifically for the fast-paced, highly m...

Daily Bulletin - avatar Daily Bulletin

Reporting Tools in Cybersecurity and Penetration Testing

Reporting is a critical part of every penetration testing engagement. After vulnerabilities have been identified and verified, the findings must be documented clearly and systematically to inform deve...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals